Mediwatch (MDWU)

Mediwatch plc, through its subsidiaries, engages in the development and marketing of medical devices used in the diagnosis of urological disorders and the detection of early prostate cancer. It offers ultrasound products that include Portascan+, a portable real-time ultrasound bladder scanner; and Multiscan PVR, a portable real-time bladder scanner for scanning bladder volume. The company also provides urodynamics products, which consist of Urodyn+, a wireless uroflow meter; Portaflow and Portaflow advanced, which provide uroflow data and tracings for male, female, and pediatric patients in various point-of-care environments; Clinic Sensic and Portable Sensic systems, which are urodynamics systems; and Duet Encompass system for diagnosing voiding disorders and incontinence. Its urodynamics products also comprise Duet LOGIC G2, which provides protocol applications with a suite of options, such as video urodynamics, urethral stress profile analysis, automated leak point pressure analysis, anorectal manometry, patient database management, and networking and remote PC operations. In addition, the company offers urodynamics disposables, including water-filled vesical, abdominal, and UPP catheters, as well as spincter and vaginal electrodes, surface electrodes, St Mark’s electrodes, infusion and perfusion tubes, and disposable and reusable pressure transducers; and Erectease, a vacuum pump for filling the penis with blood and simulating a natural erection. Further, it provides biochemistry products that include PSAwatch, a prostate cancer screening system with age specific range; Bioscan, a reader system; and BTA, a bladder cancer test. The company sells its products in the United States, the United Kingdom, Europe, and internationally. Mediwatch plc was founded in 1996 and is based in Rugby, the United Kingdom. As of January 27, 2014, Mediwatch plc was formerly a subsidiary of Laborie Medical Technologies Europe Limited. Mediwatch plc went out of business.